Form 4 for AIM AIM ImmunoTech Inc.
Accepted 2021-11-24 00:00:00 ET · period of report 2021-11-24 · accession 0001702626-21-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-24 | 2021-11-24 | AIM | EQUELS THOMAS K. | CEO, Pres, Dir | A - Grant | $1.29 | +11.6K | 267.4K | +5% | +$15.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-24 | A | A | 11,627 | $1.29 | 267,426 | D | — | — |